⚕ GalenOps CRO console
← SITE012 (BRA)

SITE012-0382

completed
Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer Phase III · Site: SITE012 (BRA) (Dr. Kowalski) · consented 2023-05-30
Adverse events
8
Serious AEs
1
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-06-18 (study day 9); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-06-30 (study day 21); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2023-07-26 (study day 47); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Rash — outcome: RECOVERED/RESOLVED; onset 2023-08-11 (study day 63); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-08-14 (study day 66); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-09-06 (study day 89); relationship: not assessed

severe serious assessed 2026-08-18

Grade 4 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-09-08 (study day 91); relationship: Y; serious criteria: life-threatening

moderate assessed 2026-08-18

Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-09-08 (study day 91); relationship: N

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.